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388 Z. Xiong et al.up-regulates expression of different cell lineage markers as β-Tubulin III (for neurons) and O4 (for oligodendrocytes), while the
expression of GFAP (for astrocytes) remains unchanged, as evidenced by quantitative PCR, immunofluorescence microscopy
and Western Blot assay. It is shown that the plasma-increased nitric oxide (NO) production is a factor in the fate choice and
differentiation of NSCs followed by axonal growth. The differentiated NSC cells matured and produced mostly cholinergic and
motor neuronal progeny. It is also demonstrated that exposure of primary rat NSCs to the microplasma leads to quite similar
differentiation effects. This suggests that the observed effect may potentially be generic and applicable to other types of
neural progenitor cells. The application of this new in vitro strategy to selectively differentiate NSCs into neurons represents a
step towards reproducible and efficient production of the desired NSC derivatives.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.Introduction
Neural stem cells (NSCs), with their ability to differentiate into
mature cell types provide an unlimited source of ‘rawmaterial’
for regenerativemedicine therapies ofmany incurable diseases
(Bergmann and Frisén, 2013). However, applications of NSCs in
regenerative medicine are hampered by the lack of insufficient
methods for directed differentiation. Cell lineages derived
from NSCs including neurons, oligodendrocytes and astrocytes
are of significant interest for many applications in regenerative
medicine and medical treatments of traumatic injuries of
neural system (Hernández-Benítez et al., 2012; Rossi and
Cattaneo, 2002).
Neurological diseases (NDs) generally affect the cen-
tral, peripheral, and vegetative nervous systems. They
mainly effect by functional disruption of feelings, motions,
and consciousness. NDs include brain trauma, spinal cord
injury, crania-cerebral, Alzheimer's and Parkinson's diseases
(Bjorklund and Lindvall, 2000; Breunig et al., 2011; Grois et
al., 1998; McKay, 1997; Rodriguez et al., 2009; Sleeper et al.,
2002). Presently available treatments of nervous system
diseases include: 1) traditional drug therapy in which drugs
are used as a source of nutrition for the recovery of damaged
nerve cells; 2) gene therapy; and 3) transplantation of central
nervous tissues (Sunde and Zimmer, 1981). However, the
progress in approaches based on nervous tissue transplanta-
tion is quite limited, in part due to ethics regulations related
to embryonic brain. Recently, a new method based on neural
stem cells isolation and cloning has been employed as a
successful in vitro strategy for the treatment of nervous
system diseases (Reynolds and Weiss, 1992; Temple, 2001).
NSCs exhibit the potency to differentiate into the main
phenotypes in the nervous system (e.g., cortical neurons)
and as such show great potential to resolve neurological and
neurotraumatic disorders without raising ethics issues (Breunig
et al., 2011).
The key purpose of cultivating neural stem cells in vitro
is to control and enhance the cell fate commitment,
differentiation into well-resolved cell types, proliferation,
and migration. Therapeutic use of NSC differentiation into
neurons for tissue transplantation to treat nervous system
disorders is an important hallmark of stem cell research
(Temple, 2001). This method is considered one of the most
promising therapies for neurodegenerative and neuro-
traumatic diseases. Previous reports have shown that
cytokines, chemicals, Chinese medicines, selected pro-
teins, hormones, electrical stimulation, and local environ-
mental factors could affect the differentiation of NSCs (Boyer
et al., 2005; Chambers et al., 2003; Flanagan et al., 2006;Hwang et al., 2004; Okada et al., 2004; J.-H.Wang et al., 2006;
J. Wang et al., 2006). For example, excessive nephroblastoma
gene expression may enhance NSCs proliferation and differen-
tiation (Shi et al., 2006). Carbon nanotube ropeswith electrical
stimulation may also stimulate the differentiation of NSCs into
the neuronal lineage (Huang et al., 2012). Olfactory
ensheathing cell (OEC) conditioned medium was found to
promote axonal regeneration and functional recovery after
transplantation (Barnett, 2004; Pellitteri et al., 2009). Howev-
er, these biochemical (e.g., based on the presentation of
differentiation factors in the medium) and more recent,
nanotechnology-based methods of NSCs differentiation have
quite significant drawbacks including chemical toxicity, insuf-
ficient selectivity of cell-type-specific differentiation, glial scar
formation after transplantation, and several others (Rossi and
Cattaneo, 2002). Therefore, there is a strong demand for
new techniques for cell-type-specific, efficient, and safe
NSC differentiation.
Non-thermal (non-equilibrium) atmospheric-pressure
plasmas (Ostrikov et al., 2013), including atmospheric-
pressure room-temperature microplasma jets (MPJs) of
interest here have recently been very effective in cancer
therapy, blood coagulation, root canal treatment, wound
healing, antimicrobial and other applications (Keidar et
al., 2011; Kim et al., 2010; Kolb et al., 2008; Laroussi,
1996; Lloyd et al., 2010). There are two most common
types of the atmospheric-pressure plasmas that are used in
biomedical treatments, namely “direct” and “indirect”
plasma devices. In the first type of devices, a living tissue
acts as an electrode, while the second type of devices,
which include the MPJs, produces the plasma plumes that
emerge outside the area where the electrodes are located.
However, the reactive species and the biological effects
produced by the both plasma device types are quite
similar. The factors produced by the plasmas include reactive
oxygen species (ROS), reactive nitrogen species (RNS), ultravi-
olet (UV), as well as charged ions and electrons (Kong et al.,
2009).
ROS such as OH and O could disrupt cells from the cell
membrane to the inner nucleus through oxidation, which
results in the effective inactivation of bacteria, fungi and
viruses, or even programmed death of cancer cells (Dobrynin
et al., 2009; Imlay et al., 1988; Lu et al., 2008b; Xiong et al.,
2011). Non-thermal atmospheric-pressure plasmas can also
enhance endothelial cell proliferation (Kalghatgi et al.,
2010). These effects can be achieved by optimizing the
treatment conditions such as the plasma parameters, working
gases, and treatment time, which affect the dose of energy
exposure, which in turn determine cell fate and behavior
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these plasmas typically have plasma spots of the order of
~10–100 μm and can be used for single-cell-level treatment
(Kim et al., 2011).
This study demonstrates that treatment of murine NSCs
with nanosecond microplasma bullets produced by MPJs
induces and enhances their differentiation into a neuronal
lineage, with a high selectivity of at least 75%. It is shown
that the differentiated cells are mature and are mostly
cholinergic and motor neuronal cells. The differentiated cell
fate and lineages are identified by immunofluorescence
microscopy, qRT-PCR, and Western Blot assay analyses. The
term “selectivity” here refers to the preferential fate choice
of the cells rather than the commonly used selectivity
between different cell types. This proof-of-concept study is
also extended to primary rat NSCs to show that MPJ agitation
of stem cells may be quite a generic phenomenon and may
potentially induce similar effects in other types of stem
cells.
Results and discussion
MPJ enhances differentiation of neural stem cells
C17.2 NSC cell cultures were exposed to MPJs as shown in
Figs. 1a,b. High-speed, nanosecond-resolution photography
reveals that the plasma plume represents a train of
fast-moving micro-bullet-like plasmas (Fig. 1c). To quantify
NSCs differentiation, cell culture substrate was divided into
3 zones as shown in Supplementary Fig. S2. Zone A with a
diameter of 3 mm, where cells were directly exposed to the
plasma resulted in cells dispersion due to gas flow (Fig. 2b);
zone B with a diameter of 18 mm, where the cells exposed
indirectly showed significant cell differentiation after 48 h
of the plasma treatment (Fig. 2c) compared to control
untreated cells (Fig. 2a), while zone C (outer edges) showed
no plasma effect (data not shown).
The results in Fig. 2 also showed that the plasma treatment
altered the cell morphology with clear neurites and cell body
extensions appearing after the exposure. Some neurites were
longer compared to cell body extensions. This shows that
differentiated cells are more mature and longer compared to
undifferentiated NSCs. All these observations indicate that the
plasma treatment enhances the differentiation of C17.2-NSCs.
The differentiation rates of NSCs on the 2nd, 4th and 6th
days after the plasma treatment were determined as shown in
Fig. 3. In the control group, only 7.33 ± 0.8% cells differenti-
ated, which is 4 times less than after the plasma treatment.
Four days later, the differentiation rates are 28.74 ± 1.05%
and 77.3 ± 5.26% for the control and the plasma treated group
in zone B, respectively. On day 6, the differentiation rate in
the control group was 55.86 ± 2.74%, while more than 90%
cells differentiated in the plasma-treated group. These
experimental results show that the plasma treatment signif-
icantly enhances the differentiation of C17.2-NSCs.
Characterization of plasma-inducedNSCs differentiated
cell lineages
NSCs are functionally characterized as cells with the capacity
to proliferate, self-renew, and produce populous progeny thatcan differentiate into neurons, astrocytes and oligodendro-
cytes (Borrell and Reillo, 2012; Chojnacki et al., 2012; Rossi
and Cattaneo, 2002). The microplasma treatment altered the
NSCs morphology and significantly enhanced cell differentia-
tion as shown above. The next step is to identify the specific
types of cells produced from NSCs after the plasma exposure.
Immunofluorescence assay was used to identify different
cell lineages. With the changes in protein expression profiles,
NSCs can differentiate into three different cell types, as
neurons, astrocytes and oligodendrocytes. Specific markers
were chosen to define specific cell lineages. Nestin, a class VI
intermediate filament protein which is highly expressed in
NSCs and does not express in differentiated cells, has been
utilized as a biologicalmarker to identify undifferentiated NSCs
(Kronenberg et al., 2003; Lendahl et al., 1990). β-Tubulin III, a
cytoskeletal protein whose expression increases during axonal
outgrowth, is expressed exclusively by neurons and considered
a specific marker for neurons (Lee et al., 1990). Glial fibrillary
acidic protein (GFAP), which is thought to help in maintain-
ing astrocyte mechanical strength and the shape of cells, is
primarily expressed by astrocytes specifically (Goss et al.,
1991). Adenomatous polyposis coli (APC) is primarily ex-
pressed by oligodendrocyte cells and used as an oligoden-
drocyte marker. Oligodendrocyte marker O4 persists in
immature oligodendrocytes and is commonly used as the
earliest recognized marker specific for the oligodendroglial
lineage (Bansal et al., 1989; Ono et al., 1997; Sommer and
Schachner, 1981).
Immunofluorescent results (Fig. 4a) showed that the 60 s
plasma treated C17.2-NSCs cultured for 6 days after the
plasma exposure presented differential expression patterns
for protein markers which indicated various cell lineages.
Protein expression for nestin (+, green) which is a biomarker
for NSCs, decreased; β-Tubulin III (+, red) which is a neuron
marker, significantly increased; O4 (+, green) as an oligoden-
drocyte marker slightly increased; and GFAP (+, red) as an
astrocyte marker remained unchanged compared to control
groups. Statistical data analysis of three-directional differen-
tiation of C17.2-NSCs was performed across 8 randomly
selected view-fields of tested samples by using Image-Pro
Plus software (Fig. 4b).
Most of the C17.2 cells differentiated into neuronal lineage
(~75%) in the 60 s plasma treated group compared with ~35%
in the control group. However, in the other two differentiation
lineages, the amount of oligodendrocytes was low (less than
1% in the control group) and increased to ~8% in the 60 s
plasma treated group; the abundance of astrocytes (~18%)
with or without the plasma treatment has not changed. From
Fig. 4 it is clearly seen that the extensions of the cells treated
with the plasma are much longer compared to the untreated
and gas-flow exposed samples. Moreover, the number of cells
that produce the extensions is clearly much larger in the
plasma-treated sample which is clearly seen by comparing the
neutral gas flow treated and the plasma-treated samples.NSCs differentiation rates and morphological analysis
C17.2-NSCs differentiated into bipolar or multi-polar neu-
rons with long neurites and extended cell body after the
plasma treatment compared to short neurites in control
untreated cells (Fig. 4a). The observed dense connections
Figure 1 Atmospheric-pressure microplasmas used in the regulation of differentiation of neural stem cells. (a) Schematic of the
experimental set-up; (b) Photograph of the plasma jet impacting on NSCs; (c) High-speed photographs of the microplasma bullet
propagating to cells in the culture dish taken by a high-speed ICCD camera from the syringe nozzle.
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tion of a three-dimensional neural network. Morphological
analysis of neurons in the untreated control and the plasma
treated groups showed significant differences in the den-
dritic area (Fig. 5a), number of primary dendrites (Fig. 5b)
and neurite length (Fig. 5c) of the neurons. These results
demonstrate that the average dendritic area increased from
~300 μm2 to 800 μm2, the number of primary dendrites
increased up to 3 times whereas the length of neurites
increased from ~160 μm to 280 μm. These data confirm that
the plasma treatment effectively induces selective neuronal
differentiation of NSCs.Identification of specific neural lineages biomarkers
after the plasma exposure
To confirm specific neural cell lineages, quantitative PCR and
immunoblotting assays were used to measure gene expression
after the plasma treatment. Nestin, β-Tubulin III, GFAP and
Olig2 genes were quantified by qRT-PCR after 2, 4, and 6 days
of the plasma treatment. The results showed that the plasma
exposure down-regulated Nestin expression which means that
the number of undifferentiated NSCs is much less compared to
the untreated control group (Fig. 6a). However, the plasma
treatment upregulated the gene expression for β-Tubulin III
(Fig. 6b) andOlig2 (Fig. 6d)which are biomarkers for neurons andFigure 2 Ordinary inverted phase contrast light microscope ima
group; (b) area A in the plasma-treated group; (c) area B in 60 s plaoligodendrocytes; this indicates the effective differentiation of
NSCs into neurons and oligodendrocytes. Olig2 expression
after the plasma treatment showed different variations with
respect to the control sample at 2 days and 4/6 days. GFAP
expression was not affected after the plasma treatment
(Fig. 6c).
We further confirmed our qRT-PCR gene expression
results by Western Blot analysis (Fig. 7) to measure protein
levels of specific neuronal biomarkers after the plasma
treatment. The plasma exposure reduced Nestin protein
expression, upregulated β-Tubulin III and APC which con-
firmed the enhanced NSCs differentiation into neurons and
oligodendrocytes after the plasma treatment. Similarly as
observed in qRT-PCR, protein expression for GFAP was not
affected after the plasma exposure. These results determine
that the plasma exposure enhances the differentiation of NSCs
into neurons and oligodendrocytes.
Possible role of reactive plasma species
MPJs produce various reactive agents, including charged species
(e.g., positive or negative ions), ROS (O, O2⁎, OH⁎, etc.), and
nitric oxide (NO). These active species have different biological
functions and mechanisms to interact with bacteria, fungi,
viruses, cancer cells and tissues and are also implicated in
nanoscale synthesis in reactive plasmas (Dobrynin et al., 2009;
Kogelschatz, 2003; Laroussi, 2005; Walsh et al., 2006). Toges of the cell differentiation after 2 days culture. (a) Control
sma-treated group.
Figure 3 Differentiation rate of the cells for the control group
and the 60 s plasma-treated group in zone B after two, four, and
six days culture.
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differentiation, active species in the plasma plume were
measured. A typical optical emission spectrum from 200 nm to
800 nm of the plasma plume shows He and NO, and excited O,
OH, N2, N2+ (Supplementary Fig. S3) species. The plasma bullet
contains excited and long-living species thatmay serve as active
factors for NSC differentiation. In particular, biologically-
relevant NO species were detected in the 200–300 nm spectral
range (Yan et al., 2012).
Optical emission spectrum shows that the microplasma
generates OH, O, NO and other reactive species. The reactive
oxygen species (ROS) are generated through
He  þO2→He þ Oþ2 þ e ð1Þ
Heþ þ O2→He þ Oþ þ O ð2Þ
Oþ2 þ e→2O ð3Þ
O þ H2O→2OH ð4Þ
Atomic oxygen (O) is hard to dissolve in liquids, so it
cannot directly react with the C17.2-NSCs as the cells are in
the culture medium. The characteristic time of reaction (4)
that generates OH species can be estimated to be as long as
6 s (Liu et al., 2010; Waskoenig et al., 2010). Presumably, O
only plays an indirect role in induction of C17.2-NSCs
differentiation. However, O could react with N2 to produce
NO, which can dissolve in liquids and may be an active factor
responsible for NSCs differentiation.
As a neurotransmitter, NO has been previously shown to
regulate NSCs proliferation and differentiation (Bansal et al.,
1989; Boulu et al., 1994; Calabrese et al., 2007; Cheng et al.,
2003). Exogenous NO is also implicated in neuronal differenti-
ation, proliferation, and axonal growth (Arnhold et al., 2002).
Moreover, previous measurements demonstrated that the
plasma treatment increases both the extra- and intra-cellular
NO concentration (Yan et al., 2012). The results of this work
show that after 60 s of the plasma treatment, concentration of
NO increased in the cell culture medium (Supplementary Fig.
S4a). Additionally, we observed that intracellular NO levels
also increased after the plasma treatment (Supplementary Fig.
S4b).We have also ascertained that NO species in general
(e.g., produced by other means) exert a quite similar effect
on the cells. These results have been obtained by selectively
adding NO donors (SNP) and NO scavengers (Hgb) to the cell
medium, untreated, treated with gas flow, and plasma treated,
to obtain a systematic picture of the effect of NO species. The
results summarized in Supplementary Fig. S5 suggest that the
effects of the microplasma and NO donors (SNP) appear to be
quite similar and both lead not only to the enhanced
neuronal differentiation but also to the enhanced maturity
of the neuronal cells, as evidenced by markedly stronger
up-regulation of both β-Tubulin III and NF200.
These experiments support our conclusion thatmicroplasma-
generated NO species are indeed important factors in inducing
stem cell differentiation. Essentially, the differentiation of
NSCs is mediated by related gene expression/regulation (Liste
et al., 2007). Thus, our experimental data indicate that NO
may indeed be an active factor produced by the plasma to
promote the NSC differentiation via stimulating related gene
expression/regulation. Further research is required to explore
specific mechanisms of the effect of other plasma-generated
reactive species to induce NSCs differentiation which in turn
can be used for nervous system disorder treatments.
Neuronal fate specification
We have also used combinatorial immunofluorescence and
Western Blot analyses to determine if the differentiated
neural cells mature and also to identify what specific types
of neuronal cells emerge as a result of the microplasma
agitation. Different biological markers were used, such as
NF200 (for mature neurons), ChAT (for cholinergic neu-
rons), LHX3 (for motor neurons), GABA (for GABAergic
neurons), Serotonin (for serotonergic neurons), and TH (for
dopaminergic neurons). These results are summarized in
Fig. 8. The immunofluorescence studies (Fig. 8a) suggest
that large numbers of mature neurons, cholinergic and
motor neurons appear in the plasma-treated group. Fur-
thermore, GABAergic and serotonergic neurons were rarely
seen in the images, whereas no dopaminergic neurons were
detected. These results were cross-referenced by the
Western Blot analysis of the expression of NF200, ChAT
and LHX3 biomarkers presented in Fig. 8b. These results
show a strong up-regulation of the expression of all these 3
markers, consistently with the immunofluorescence imaging
results in Fig. 8a. This indicates that the plasma treatment
promoted the maturation of the differentiated neurons as well
as the preferential differentiation of the NSCs into cholinergic
andmotor neurons. However, because LHX3 is also a biomarker
of interneurons, we have conducted the additional test using a
more specific marker Hb9 of the motor neurons (Thaler et al.,
2002), see Fig. 8b. One can clearly see a strong expression of
Hb9 in the plasma-treated group, which further confirms the
effective formation of motor neurons as a result of the
microplasma treatment.
Study of MPJ effect on primary rat NSCs
To show that the observed microplasma effects could poten-
tially be generic and applicable to other neural progenitor cells,
we have studied the effect of MPJs on primary rat NSCs. These
Figure 4 (a) Immunofluorescence detection of C17.2-NSCs untreated (left), gas flow with no plasma (middle), and 60 s
plasma-treated (right) for 6 days culture. Nestin (+, Green)/Hoechst; β-Tubulin III (+, Red)/Hoechst; O4 (+, Green)/Hoechst; GFAP
(+, Red)/Hoechst. Blue nuclear counter stain is Hoechst 33258. (b) Bar charts of the percentage of differentiated cells in the control,
gas flow and 60 s plasma-treated group after 6 days culture.
392 Z. Xiong et al.results are summarized in Fig. 9. Very similar procedures were
followed for this type of cells. FromFig. 9b, it follows that about
95% of untreated cells showed a strong expression of Nestin
biomarker, indicating that the NSCs were in an appropriate
undifferentiated condition before the microplasma exposure.
The gas flow did not induce any significant morphological
changes, while the MPJ treatment led to the very significant
changes evidenced by the pronounced neurite branching and
outgrowth, as can be clearly seen in Fig. 9c. Moreover, the
neurite length was much larger in the microplasma-treated
samples. These results are consistent with the immunofluores-
cence studies of the expression of β-Tubulin III and O4biomarkers specific to the neuronal and oligodendrocytal
lineages, respectively. The results in Fig. 9d clearly show a
much stronger branching and the emergence of much longer
neurites in the plasma-treated samples. Likewise, the expres-
sion of O4 indicates the development of the oligodendrocytal
progeny. These results suggest that the MPJ exposure also
induces a qualitatively similar effect on another type of neural
progenitors.
The results of quantitative image analysis of the rat NSC
differentiation are shown in Fig. 10. It is clearly seen that in the
plasma-treated group, the percentage of undifferentiated cells
becomes much smaller (Fig. 10a) while the number of neurons
Figure 5 Bar chart of the neuronal morphology analysis in the
control and the 60 s plasma-treated group after 6 days culture.
(a) Dendritic area; (b) Number of primary dendrites; (c) Neurite
length.
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average neurite length of the plasma-treated rat NSCs is
also nearly two times larger compared to the control
sample (Fig. 10d). Therefore, there is a possibility that
the process conditions may be adjusted to optimize the
quantitative MPJ effects on the primary rat NSCs, as well
as possibly extended to other types of neural progenitor
cells.Conclusion
Therefore, atmospheric-pressure plasma exposure represents a
promising new approach towards highly-controlled NSCsdifferentiation to be utilized in various medical treatments of
human neurological disorders and injuries of the CNS. This study
showed that the atmospheric-pressure microplasma treatment
produced neurons with long neurites and extended cell bodies.
The quantized microplasma bullets of nanosecond duration
significantly increased the differentiation rates compared to
un-treated control neural stem cells. Our experimental data
from immunofluorescence, qRT-PCR, and immunoblotting
showed that the plasma-induced C17.2-NSCs differentiation
was predominately towards a neuronal lineage (~75%), also
accompanied by an increased population of oligodendroglial
lineage. The cell fate specification study identified that the
differentiated cells matured and preferentially produced
cholinergic and motor neurons. Importantly, a quite similar
effect was demonstrated using another type of neural
progenitors, namely, primary rat NSCs.
Finally, this study demonstrates that atmospheric-pressure
microplasmas represent an effective and safe tool for the
differentiation of the NSCs selectively into neuronal lineage.
Moreover, this finding may potentially be quite generic and
possibly used to induce effective and selective differentiation
of other types of neural progenitor cells. Further studies in this
direction are therefore highly warranted.Materials and methods
Cell Culture
Murine immortalized neural stem cell line C17.2 (C17.2-NSC,
cell line identification is shown in Supplementary Fig. S1)
(Snyder et al., 1992), were maintained in Dulbecco's modified
Eagle medium (DMEM, Gibco BRL, Grand Island, NY) supple-
mented with 10% fetal bovine serum (FBS), 5% horse serum (HS)
and 1% penicillin/streptomycin (Hyclone, Logan, UT) in a
humidified atmosphere of 5% CO2 and 95% air at 37 °C. The
logarithmic phase C17.2-NSC cells were detached by
trypsin and planted into a 12-well plate with the density
of ~2 × 104 cells/ml. Following cell attachment, the cells
were washed twice with serum-free DMEM and cultured in
differentiation medium consisting of DMEM/F-12 (Hyclone,
Logan, UT) with 1% N-2 supplement (Gibco BRL, Grand
Island, NY, USA) for 48 h before plasma treatment. In the
immunofluorescence experiment, cells were seeded on
20 mm (diameter) poly-D-lysine (Sigma Chemical Co., St.
Louis, MO, USA) coated glass coverslips in the 12-well plate
with differentiation medium. Sham-treated controls were
kept in differentiation medium at room temperature during
the experimental procedure to ensure uniform treatment
conditions.
Primary rat neural stem cells were isolated from the
hippocampus of post-natal (P0–P1) SD rats according to
methods described previously (Hu et al., 2004). The
neurospheres derived from primary NSCs were maintained in
OriCellTM Sprague–Dawley (SD) Rat Neural Stem Cell Growth
Medium (Cyagen, USA) on uncoated T25-flasks (Corning). All
the experiments were performed with cells that had under-
gone two passages. For the differentiation of Rat NSCs,
neurospheres were seeded onto poly-D-lysine coated cover-
slips in the 12-well plate with differentiation medium, which
consists of DMEM/F12, 2% B-27 (Gibco) and 1% FBS.
Figure 6 Relative gene expression of mRNA level analysis by qRT-PCR of untreated and 60 s plasma-treated cells. (a) Nestin; (b)
β-Tubulin III; (c) GFAP; (d) Olig2.
Figure 7 Western Blot analysis of nestin, β-Tubulin III, APC,
GFAP, and GAPDH expression in C17.2-NSCs in the control group,
the gas flow with no plasma group, and the 60 s plasma-treated
group after 6 days culture.
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A single-electrode atmospheric pressure room-temperature
plasma jet device was used to treat the neural stem cells as
shown in Fig. 1. More details about the MPJ device can be
found elsewhere (Lu et al., 2008a). The device was driven by
a pulsed power supply with a pulse rising time of 60 ns, pulse
repetition frequency up to 10 kHz, pulse width variable from
200 ns to DC and voltage up to 10 kV. A mixture of working
He and O2 (1%) gases with the flow rate of 1 l/min was used.
The pulse frequency, pulse width, and the amplitude of the
applied voltage were fixed at 8 kHz, 1.6 μs, and 8 kV,
respectively. Total 12 samples were divided into two groups,
the control group, and the 60 s plasma treatment group.
Each group contains six samples. The distance between the
nozzle of the syringe and the cell well hole was 15 mm. After
the plasma treatment, 1 ml new differentiation medium was
added into each hole to replace the original culture, and
then incubated in a humidified atmosphere of 5% CO2 and
95% air at 37 °C. Two types of control groups were used,
namely untreated cells and cells treated with only the He and
O2 (1%) gas flow, without the plasma generation; these results
are shown separately where appropriate. This is used to show
that the effect of the gas flow alone is much weaker compared
with the plasma effect. In principle, gas flows may affect stem
cell differentiation, potentially through biochemical, ther-
mal, and mechanical agitation factors. The helium gas is inert
hence the biochemical pathway is unlikely. A similar conclu-
sion holds for the thermal pathway because the temperature
of the plasma jet is close to ambient conditions of experi-
ments. Typical velocities of gas atoms/molecules in the gas
flow (“wind”) are just about 10 m/s which is comparable witha typical sea breeze speed. This gentle gas flow is very unlikely
to generate the levels of mechanical stress which is used for
mechanical agitation of stem cells. Therefore, pure mechan-
ical agitation by the near-room-temperature gas flow is
unlikely, which is consistent with our observations. More
details about the microplasma jet device, different zones
in the samples affected by the treatment and the optical
emission spectra generated by the MPJs can be found in
Supplementary Sections S2, S3, and S5.
Figure 8 Neuronal fate specification studied by (a) immunofluorescence and (b) Western Blot analyses. Strong expression of NF200,
ChAT, and LHX3 biomarkers of the mature, cholinergic, and motor neurons, respectively is confirmed for the plasma-treated group by
the results of the both analyses. Additional Western Blot test using Hb9 biomarker specifically confirms the formation of motor
neurons in the plasma-treated group (B).
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To assess morphological changes in NSCs following the plasma
treatment, the plates were examined with an inverted phase
contrast light microscope (XD-202, Nanjing Jiangnan Novel
Optics Co., Ltd) and photos were taken every day. In order to
compare the differentiation rate of the control group and the
plasma treated group in zone B, eight different visual fields
were picked randomly for each sample every other day. The
total number of cells and the number of differentiated cells in
each visual field were counted. The cell with one or more
neurites was considered differentiated. The differentiation
rates on the 2nd, 4th, and 6th days were then calculated
according to the number of differentiated cells versus the
total number of cells.
Immunofluorescence and quantification
Cells were seeded on 20 mm (diameter) poly-D-lysine coated
coverslips for immunofluoresence analysis. Samples were fixed
with 4% paraformaldehyde (Beyotime, Jiangsu, China) for
20 min followed by permeabilization with 0.2% TritonX-100 in
PBS for 10 min at room temperature. The cells were then
washed three times with PBS and incubated in 10% goat serum
for 1 h to block any non-specific interactions. Then the samples
were incubated with primary antibody at 4 °C overnight. The
following antibodies were used to detect antigens: mouse
anti-nestin (Beyotime, Jiangsu, China), rabbit anti-β-Tubulin III
(Sigma Aldrich, USA), rabbit anti-GFAP (Dako, Denmark), and
mouse anti-O4 (R&D Systems, USA), rabbit anti-NF200 (Sigma),
rabbit anti-ChAT (Sigma), rabbit anti-LHX3 (Sigma), rabbit
anti-Tyrosine Hydroxylase (Abcam, Cambridge, MA), rabbit
anti-GABA (Sigma), rabbit anti-serotonin (Abcam, Cambridge,
MA). After washing with PBS, cells were further incubated with
Cy3-conjugated or Alexa Fluor 488-conjuated secondary
antibodies (Jackson Immuno Research, USA) for 1 h at room
temperature. Hoechst 33258 (Beyotime, Jiangsu, China) stain-
ing was used to label nuclei. Finally, the samples were imagedusing a Nikon fluorescent microscope (80i, Nikon, Tokyo,
Japan). Images were combined in figures using Adobe
Photoshop CS3. For the morphology analysis of neuron
(β-Tubulin III+ cells) and quantification of the percentage of
cells producing a given marker protein, at least 8 randomly
selected fields were photographed in each testing sample and
the numbers of positive cells were determined relative to the
total number of Hoechst 33258-labelled nuclei using Image-Pro
Plus software.Quantitative real-time PCR (qRT-PCR)
Cells were treated with or without plasmas and cultured for
the indicated time points. Total RNA was extracted with the
RNAprep pure Cell/Bacteria Kit (Tiangen Biotech, Beijing,
China) according to the manufacturer's instructions. About
1.5 μg RNA from each treatment was reverse transcribed
into cDNA, which was subsequently served as the template
for qRT-PCR, using RevertAid first-strand cDNA synthesis kit
(Fermentas, USA). The primers (Supplementary Table S1) for
qRT-PCR were designed using Primer Express software. Using
the SuperReal PreMix Plus (SYBR Green) reagents (Tiangen
Biotech) combined with gene-specific primers, qRT-PCR was
performed on a Bio-Rad CFX-96 detection system (Bio-Rad,
Hercules, CA, USA) using three stage amplification program.
The specificity and amplification efficiency of all primers for
each genes were tested prior to qRT-PCR experiments. The
amplification efficiencies for each gene were between 0.9
and 1.1 and the specificity was confirmed by the melting
curve analysis that a single peak indicated that a single DNA
sequence was amplified during PCR. A housekeeping gene
(GAPDH) was used as the reference gene that served as a
benchmark for normalization. Each sample was tested in
triplicate, and the samples obtained from three independent
experiments were used for the analysis. The differences in
gene expression levels were calculated using the 2−ΔΔCt
method (Lendahl et al., 1990).
Figure 9 Effect of MPJ exposure on the primary rat NSCs. a: Neurospheres in suspension culture. b: The primary state of the
primary rat NSCs was undifferentiated as evidenced by the strong expression of Nestin NSC detected by immunofluorescence imaging.
c: Observation of morphological changes following the He/O2 gas and MPJ exposure shows the pronounced branching and elongation
of neurites after the plasma treatment. d: Immunofluorescence for the specific neural lineage biomarkers. The expression of
β-Tubulin III and O4 biomarkers is much stronger in the plasma treated group compared to the untreated and gas flow treated groups.
The MPJ exposure strongly promotes the differentiation of the primary Rat NSCs into the neuronal and oligodendrocytal progeny.
396 Z. Xiong et al.Western Blot analysis
After the plasma treatment, cells were cultured for 6 days and
then harvested in lysis buffer (Beyotime, Jiangsu, China) in the
presence of protease inhibitor PMSF (Beyotime, Jiangsu, China)
(Zhao et al., 2013). A quantity of 30 μg of total cellular proteins
per lanewas separated on 10% sodium dodecyl sulfate-polyacryl
amide gel electrophoresis (SDS-PAGE) and transferred onto
nitrocellulose membrane. After blocking with 5% nonfat dried
milk, the membranes were incubated with the antibodies
against nestin (SantaCruz, CA), β-Tubulin III, GFAP, APC
(SantaCruz), Hb9 (Bioss, China), LHX3, NF200, ChAT, and
GAPDH (SantaCruz). Horseradish peroxidase (HRP)-conjugated
goat anti-mouse or goat anti-rabbit IgG (SantaCruz) were used
to detect the primary antibodies above. Detection oftransferred proteins (antigens) were performed with an
enhanced chemiluminescence detection kits (Millipore,
USA) using ChemiDocXRS+ (Bio-Rad, USA). GAPDH was used
as a control protein because its expression was the same
for untreated samples, samples exposed to the gas flow
only, and the plasma-treated samples, as can be seen in
Figs. 7 and 8, as well as Supplementary Fig. S5.
Microplasma diagnostics
A half meter spectrometer (Princeton Instruments Acton
SpectraHub 2500i) is used to measure the optical emission
spectra (OES) of the plasma plume by using a fiber to collect
the light. The distance between the fiber end and the
plasma plume is set at 15 mm. Plasma bullets, generated by
Figure 10 Quantitative analysis of the differentiation of rat NSCs. (a) % of cells expressing Nestin+ (biomarker for undifferentiated
NSCs); (b) % of cells expressing β-Tubulin III+ (biomarker for neurons); (c) % of cells expressing O4+ (biomarker for oligodendrocytes); (d)
average neurite length of differentiated neurons. All the results are shown for the control, gas-flow-only, and plasma-treated groups.
397Selective neuronal differentiation of NSCs induced by nanosecond microplasma agitationthe plasma device and propagated from the syringe nozzle to
the C17.2-NSCs samples, were captured by a high-speed
ICCD camera (PI-MAX2: 1003RB-FG-46, wavelength from 200
to 900 nm). The distance between the nozzle and the sample
is set at 15 mm.
Nitric oxide effect characterization
The extracellular and intracellular NO concentrations were
determined using NO detection kit (Beyotime, Jiangsu,
China) according to instructions provided by the manufac-
turer. For the detection of extracellular NO concentration,
conditioned medium from C17.2-NSCs cultures after 6 days
incubation was collected as samples for measurement. For
the intracellular NO concentration determination, the cells
cultured for 6 days after the plasma treatment were washed
twice with ice-cold PBS after removing the medium, and
then were lysed using cell lysis buffer (Beyotime, Jiangsu,
China). The lysates were collected and centrifuged at 4 °C
for 5 min. The supernatants were collected as samples to be
tested. Assays were carried out in triplicate, and a standard
curve using NaNO2 was generated for each experiment for
quantification. Briefly, 50 μl of samples or standard NaNO2
were mixed with 50 μl of Griess reagent I and 50 μl of Griess
reagent II in a 96-well plate at room temperature for 10 min.
The absorbance was measured at 560 nm on a microplate
reader (Sunrise, Tecan). NO concentration was calculated with
a reference to a standard curve of NaNO2 generated by known
concentrations.
To ascertain that NO speciesmay induceNSC differentiation,
we have complemented the NO concentration measurements
with the inverted phase contrast light microscope imaging and
Western Blot analysis. C17.2-NSCs were divided into eight
groups: non-treated control, He/O2 gas flow (60 s), plasma(60 s), SNP (100 μM, NO donor), Hgb (20 μM, NO-scavenger),
He/O2 gas flow and Hgb co-treated group, plasma and Hgb
co-treated group, SNP and Hgb co-treated group. As seen in
Supplementary Fig. S5A, C17.2-NSCs with the plasma treatment
showed similar differentiation effects as the SNP-treated group.
Meanwhile, the NO-scavenger reduced the plasma-induced
NSCs differentiation similarly in SNP treated NSCs (positive
control). To study NO production in each group (Supplementary
Fig. S5B), plasma-treated groups were detected immediately
after the treatment. Likewise, SNP treated groups were
detected 48 h after SNP were added (SNP can release NO slowly
in themedium). The results of NO concentration measurements
were consistent with the results of Western Blot analysis for
the expression of neuronal markers β-Tubulin III and NF200
(Supplementary Fig. S5C), which both markedly up-regulated
both in the plasma and the SNP treatment groups. However,
these effects were attenuated by the Hgb NO scavenger.Statistical analysis
GraphPad Prism 5.0 software was used for statistical analysis.
Results were expressed as the mean ± standard error of the
mean (SEM) of triplicate samples and reproducibility was
confirmed in at least three independent experiments. Student's
t-tests were used to compare the two groups. Differences were
considered significant at P b 0.05 or P b 0.01.Neuronal fate specification study
To study if the differentiated neurons develop into mature
neurons as well as the specific neuron types generated, the
following procedures were used. The C17.2-NSCs were treated
with the microplasma for 60 s, and after a continuous
398 Z. Xiong et al.differentiation for 6 days, immunofluorescence studies were
used to identify neuron subtype-specific markers, such as
NF200 (mature neurons), ChAT (cholinergic neurons), Hb9 and
LHX3 (motor neurons), GABA (GABAergic neurons), Serotonin
(serotonergic neurons), and TH (dopaminergic neurons).
Because NF200, ChAT, and LHX3 biomarkers showed very
strong immunofluorescence responses in the plasma-treated
C17.2-NSC cells (Fig. 8a), the expressions of the same
biomarkers were also positively detected in the Western Blot
analysis (Fig. 8b). The expression of Hb9 was studied in the
Western Blot analysis to more specifically identify the
development of motor neurons (Fig. 8b).Study of MPJ effect on primary rat NSCs
This proof-of-principle study basically followed similar
approaches that were used for C17.2-NSCs and described
above. Neurospheres were processed in suspension culture
(Fig. 9a). The neurospheres were allowed to adhere on
poly-D-lysine coated coverslips for 24 h. Immunofluores-
cence was used to detect the marker (Nestin) for NSCs
(Fig. 9b). To observe the morphological changes (Fig. 9c)
induced by the He/O2 gas flow and the microplasma
treatment, the neurospheres were seeded on poly-D-lysine
coated coverslips for 24 h. Then, the gas flow and the plasma
treatment (90 s) were performed, followed by differentiation
for 4 days in differentiationmedium (DMEM/F12 + 2% B-27 + 1%
FBS). Immunofluorescence studies were used to identify the
biomarkers for the specific neural lineages. A similar set of
biomarkers was used as in the C17.2-NSCs case. The effect of
the MPJ exposure on the primary rat NSCs was qualitatively
similar to the C17.2-NSCs, with stronger development of the
neuronal lineage accompanied by the larger presence of
olygodendrocites. This effect was quantified in Fig. 10 using
the analysis of the immunofluorescence images in Fig. 9 by using
the Image Pro software.Acknowledgments
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